(Q33977229)

English

Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R L Patron

1

1 reference

Europe PubMed Central

30 July 2017

M W Climo

2

1 reference

Europe PubMed Central

30 July 2017

B P Goldstein

3

1 reference

Europe PubMed Central

30 July 2017

G L Archer

4

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

30 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

30 July 2017

43

1 reference

Europe PubMed Central

30 July 2017

7

1 reference

Europe PubMed Central

30 July 2017

1754-1755

1 reference

Europe PubMed Central

30 July 2017

LYSOSTAPHIN THERAPY IN MICE INFECTED WITH STAPHYLOCOCCUS AUREUS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Lysostaphin in experimental renal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Lysostaphin: model for a specific enzymatic approach to infectious disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89356

5 July 2018

Studies in experimental staphylococcal endocarditis in dogs. VI. Treatment with lysostaphin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10390235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species

1 reference

https://pubmed.ncbi.nlm.nih.gov/10390235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/10390235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33977229&oldid=1536748585"